Forecasts data is unavailable for this security.
- 1yr ago
- 3M ago
- 2M ago
- 1M ago
Select bar for recommendation details.
S&P Capital IQ Quantitative Report
12 pages, 22 Oct 2016
Reuters Investment Profile
Ford Investor Services, Inc.
Value Graph: CTI BIOPHARMA -- CTIC
1 page, 21 Oct 2016
CTI BioPharma Corp. (CTIC) - Financial and Strategic SWOT Analysis Review
93 pages, 06 Oct 2016
Share price forecast
The 3 analysts offering 12 month price targets for
CTI BioPharma Corp have a median target of 0.75, with a high estimate of 5.00 and a low estimate of 0.00. The median estimate represents a 86.20% increase from the last price of 0.4028.
Earnings history & estimates
The next earnings announcement is expected on Nov 03, 2016.
|Average growth rate||+16.52%|
|Average growth rate||+19.02%|
Revenue history & estimates
|Average growth rate||+301.15%|
|Average growth rate||+807.69%|